Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall

GL Perrucci, E Rurali, A Gowran, A Pini, C Antona, R Chiesa, G Pompilio, P Nigro

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Marfan syndrome (MFS) is a connective tissue disorder with multiple organ manifestations. The genetic cause of this syndrome is the mutation of the FBN1 gene, encoding the extracellular matrix (ECM) protein fibrillin-1. This genetic alteration leads to the degeneration of microfibril structures and ECM integrity in the tunica media of the aorta. Indeed, thoracic aortic aneurysm and dissection represent the leading cause of death in MFS patients. To date, the most effective treatment option for this pathology is the surgical substitution of the damaged aorta. To highlight novel therapeutic targets, we review the molecular mechanisms related to MFS etiology in vascular smooth muscle cells, the foremost cellular type involved in MFS pathogenesis. © 2016 Springer International Publishing
Original languageEnglish
Pages (from-to)267-277
Number of pages11
JournalCellular and Molecular Life Sciences
Volume74
Issue number2
DOIs
Publication statusPublished - 2017

Fingerprint

Marfan Syndrome
Vascular Smooth Muscle
Smooth Muscle Myocytes
Aneurysm
Aorta
Tunica Media
Microfibrils
Thoracic Aortic Aneurysm
Surgical Pathology
Extracellular Matrix Proteins
Connective Tissue
Extracellular Matrix
Dissection
Cause of Death
Mutation
Therapeutics
Genes

Cite this

Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall. / Perrucci, GL; Rurali, E; Gowran, A; Pini, A; Antona, C; Chiesa, R; Pompilio, G; Nigro, P.

In: Cellular and Molecular Life Sciences, Vol. 74, No. 2, 2017, p. 267-277.

Research output: Contribution to journalArticle

@article{3b6d55acd5e54151b11c7110665dcac8,
title = "Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall",
abstract = "Marfan syndrome (MFS) is a connective tissue disorder with multiple organ manifestations. The genetic cause of this syndrome is the mutation of the FBN1 gene, encoding the extracellular matrix (ECM) protein fibrillin-1. This genetic alteration leads to the degeneration of microfibril structures and ECM integrity in the tunica media of the aorta. Indeed, thoracic aortic aneurysm and dissection represent the leading cause of death in MFS patients. To date, the most effective treatment option for this pathology is the surgical substitution of the damaged aorta. To highlight novel therapeutic targets, we review the molecular mechanisms related to MFS etiology in vascular smooth muscle cells, the foremost cellular type involved in MFS pathogenesis. {\circledC} 2016 Springer International Publishing",
author = "GL Perrucci and E Rurali and A Gowran and A Pini and C Antona and R Chiesa and G Pompilio and P Nigro",
year = "2017",
doi = "10.1007/s00018-016-2324-9",
language = "English",
volume = "74",
pages = "267--277",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",
number = "2",

}

TY - JOUR

T1 - Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall

AU - Perrucci, GL

AU - Rurali, E

AU - Gowran, A

AU - Pini, A

AU - Antona, C

AU - Chiesa, R

AU - Pompilio, G

AU - Nigro, P

PY - 2017

Y1 - 2017

N2 - Marfan syndrome (MFS) is a connective tissue disorder with multiple organ manifestations. The genetic cause of this syndrome is the mutation of the FBN1 gene, encoding the extracellular matrix (ECM) protein fibrillin-1. This genetic alteration leads to the degeneration of microfibril structures and ECM integrity in the tunica media of the aorta. Indeed, thoracic aortic aneurysm and dissection represent the leading cause of death in MFS patients. To date, the most effective treatment option for this pathology is the surgical substitution of the damaged aorta. To highlight novel therapeutic targets, we review the molecular mechanisms related to MFS etiology in vascular smooth muscle cells, the foremost cellular type involved in MFS pathogenesis. © 2016 Springer International Publishing

AB - Marfan syndrome (MFS) is a connective tissue disorder with multiple organ manifestations. The genetic cause of this syndrome is the mutation of the FBN1 gene, encoding the extracellular matrix (ECM) protein fibrillin-1. This genetic alteration leads to the degeneration of microfibril structures and ECM integrity in the tunica media of the aorta. Indeed, thoracic aortic aneurysm and dissection represent the leading cause of death in MFS patients. To date, the most effective treatment option for this pathology is the surgical substitution of the damaged aorta. To highlight novel therapeutic targets, we review the molecular mechanisms related to MFS etiology in vascular smooth muscle cells, the foremost cellular type involved in MFS pathogenesis. © 2016 Springer International Publishing

U2 - 10.1007/s00018-016-2324-9

DO - 10.1007/s00018-016-2324-9

M3 - Article

VL - 74

SP - 267

EP - 277

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

IS - 2

ER -